Los Angeles Capital Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.4M | Sell |
316,751
-764,377
| -71% | -$27.5M | 0.04% | 230 |
|
|
2025
Q1 | $33.7M | Buy |
1,081,128
+1,040,234
| +2,544% | +$32.4M | 0.15% | 121 |
|
|
2024
Q4 | $1.04M | Sell |
40,894
-346,803
| -89% | -$8.85M | ﹤0.01% | 606 |
|
|
2024
Q3 | $11M | Sell |
387,697
-57,851
| -13% | -$1.64M | 0.04% | 241 |
|
|
2024
Q2 | $11.7M | Sell |
445,548
-258,371
| -37% | -$6.81M | 0.04% | 243 |
|
|
2024
Q1 | $21.4M | Buy |
703,919
+297,948
| +73% | +$9.05M | 0.07% | 206 |
|
|
2023
Q4 | $11.4M | Sell |
405,971
-25,575
| -6% | -$718K | 0.04% | 255 |
|
|
2023
Q3 | $11.7M | Buy |
431,546
+126,180
| +41% | +$3.42M | 0.05% | 229 |
|
|
2023
Q2 | $9.39M | Sell |
305,366
-241,368
| -44% | -$7.42M | 0.04% | 268 |
|
|
2023
Q1 | $19.7M | Buy |
546,734
+280,435
| +105% | +$10.1M | 0.09% | 196 |
|
|
2022
Q4 | $10.5M | Buy |
266,299
+98,126
| +58% | +$3.88M | 0.05% | 272 |
|
|
2022
Q3 | $6.76M | Sell |
168,173
-85,093
| -34% | -$3.42M | 0.04% | 317 |
|
|
2022
Q2 | $10.6M | Sell |
253,266
-41,133
| -14% | -$1.73M | 0.05% | 269 |
|
|
2022
Q1 | $11.5M | Buy |
294,399
+112,068
| +61% | +$4.37M | 0.05% | 262 |
|
|
2021
Q4 | $7.27M | Sell |
182,331
-158,648
| -47% | -$6.32M | 0.03% | 306 |
|
|
2021
Q3 | $12.3M | Sell |
340,979
-629,027
| -65% | -$22.7M | 0.06% | 246 |
|
|
2021
Q2 | $39.8M | Buy |
970,006
+80,255
| +9% | +$3.29M | 0.18% | 127 |
|
|
2021
Q1 | $38.8M | Buy |
889,751
+628,606
| +241% | +$27.4M | 0.18% | 131 |
|
|
2020
Q4 | $13.1M | Buy |
+261,145
| New | +$13.1M | 0.06% | 238 |
|